| CASE REPORT |
|
| Year : 2022 | Volume
: 23
| Issue : 2 | Page : 139-141 |
|
|
Pediatric scalp psoriasis: Therapeutic response to oral apremilast: A report of two cases
Anil Kumar Panda, Farheen Begum, Maitreyee Panda, Chinmoy Raj
Department of DVL, Institute of Medical Sciences and SUM Hospital, S ‘O’A University, Bhubaneswar, Odisha, India
Correspondence Address:
Dr. Anil Kumar Panda
Department of DVL, Institute of Medical Sciences and SUM Hospital, S ‘O’A University, Bhubaneswar, Odisha
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpd.ijpd_56_21
|
|
|
Localized childhood scalp psoriasis is usually controlled with topical therapy. Therapies resistant to topical treatment require a switch to oral therapy. Standardized guidelines for treating childhood psoriasis are lacking, and there are only limited evidence-based data and approved treatments. However, in this current pandemic situation, oral immunosuppressants should be avoided, and a safer molecule-like apremilast can be a better option. We present two cases of childhood scalp psoriasis not responding to topical therapy and showing excellent results with apremilast with better safety profile.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
